Ilizarov骨搬移技术结合伤科黄水治疗胫骨骨折后感染性骨缺损的临床研究
[Abstract]:Objective: to investigate the clinical effect of Ilizarov combined with yellow water in the treatment of infectious bone defect after tibial fracture: 60 cases of post-traumatic tibia treated in Department of traumatic Orthopedics, Foshan Hospital of traditional Chinese Medicine, Guangdong Province from June 2014 to June 2016 Patients with infectious bone defect of bone fracture were studied. There were 42 males and 18 females, aged 16-56 years (mean 41.2 years). The first injury was open fracture. The course of disease was 6-24 months (mean 14.6 months), the length of bone defect was 6-14.5 cm (mean 8.8 卤1.2) cm.. There were no systemic infection symptoms on admission. Preoperative imaging examination, clinical manifestation, laboratory examination and bacterial culture showed different degree of infectious bone defect. 60 patients were randomly divided into four groups, with no statistical significance in sex, age distribution and course of disease. Group C was treated with saline before and after operation, and group D was treated with saline before and after operation. All the patients were treated with sensitive antibiotics before operation and infection control. The preoperative examination was improved, the contraindication of operation was eliminated, the surgery was performed after the infection was stabilized, and the technique of osteotomy and removal with Ilizarov external fixator was used. Flap transfer or open drainage were performed at the soft tissue defect. The bone mass was removed to the defect at the rate of 0.6-1mm/d 10 days after operation. After bone removal, the external fixator was removed according to the status of bone mineralization. The infection of the nail passage was compared among the four groups. Results: all patients completed the operation successfully, and the average operation time was (135 卤26. 8) min;. The average amount of blood loss during operation was (103 卤21.4) ml.36. The follow-up time was 9-24 months and the average time of bone transfer was 90 (60-150) days. All the patients were healed, and the healing time was 6-18 (8.86 卤3.31) months. Bone infection was also controlled. The length of distraction osteogenesis was 6-14.5 cm (mean (8.8 卤1.2) cm.A) needle infection rate was 6.67% (1 / 15); B group was 33.33%) (5 / 15), C group was 20% (3 / 15); The needle infection rate in group D was 53.33% (8 / 15). According to statistical analysis, there was significant difference among the four groups (P0.05). Before and after operation, the infection rate of nail canal could be effectively reduced by using yellow water in injury department. 9 cases had axial deviation in the process of bone transfer, and were corrected after adjustment. 11 patients suffered from skin pain caused by steel needle pulling and stopped traction for 2-3 days, and then moved on after the pain disappeared. According to the Paley score of fracture healing, 37 cases were excellent, 14 cases were good, 9 cases were middle, all the patients had improved the function of ankle and knee joint after union of bone ends. Conclusion: Illizarov combined with yellow water in the treatment of infectious bone defect after tibia trauma is effective, safe and simple, and it can effectively reduce the infection rate of post operative nail canal, so it is worth popularizing.
【学位授予单位】:湖北中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R687.3
【参考文献】
相关期刊论文 前10条
1 蒋守海;邱东新;董长红;徐明亮;郝亮;张冶;周立国;夏建军;彭爱民;;应用Ilizarov技术Ⅰ期修复伴有皮肤缺损的胫骨创伤性骨髓炎骨缺损[J];中国骨伤;2015年12期
2 冼呈;赵劲民;苏伟;劳山;花奇凯;;胫骨横向骨搬移微循环再生技术治疗糖尿病足的临床疗效观察[J];广西医科大学学报;2015年04期
3 周祥吉;薛丁山;杨富强;高学健;葛健健;范启申;;骨搬移联合皮瓣移植术在小腿医源性感染治疗中的应用[J];中国骨与关节损伤杂志;2014年12期
4 郝光亮;张贵春;曹学成;;骨搬移术治疗胫骨骨折术后感染性大段骨缺损的疗效分析[J];中国骨与关节外科;2014年05期
5 郑学建;秦泗河;彭爱民;赵巍;吴鸿飞;石磊;郭保逢;王金国;房经武;;Ilizarov技术同期治疗胫骨缺损合并马蹄足畸形[J];中华创伤骨科杂志;2013年10期
6 辛文妤;宋俊科;何国荣;杜冠华;;黄芩素和黄芩苷的药理作用及机制研究进展[J];中国新药杂志;2013年06期
7 夏继成;;紫草的研究进展[J];黑龙江科技信息;2011年34期
8 韦健全;罗莹;黄健;薛强;潘勇;郑子敏;;地黄连提取物镇痛抗炎作用及急性毒性[J];中国实验方剂学杂志;2011年16期
9 杨延龙;张丞;纪荣;国旭祺;苏永华;;紫草素促进化疗药物渗漏局部皮肤组织损伤愈合的实验研究[J];上海中医药杂志;2011年07期
10 孟祥乐;李红伟;李颜;余奇;万丽丽;郭澄;;栀子化学成分及其药理作用研究进展[J];中国新药杂志;2011年11期
,本文编号:2406211
本文链接:https://www.wllwen.com/yixuelunwen/waikelunwen/2406211.html